We are live on ! Find out more
P

Pitcairn Portfolio holdings

AUM $1.27B
1-Year Est. Return 23.64%
This Fund
S&P 500
This Quarter Est. Return
+20.57%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.83%
AUM
$1.04B
AUM Growth
+$196M
Cap. Flow
+$38.8M
Cap. Flow %
3.72%
Top 10 Hldgs %
51.37%
Holding
540
New
107
Increased
188
Reduced
193
Closed
42

Sector Composition

Rank Sector Weight
1 Consumer Staples 28.92%
2 Technology 12.57%
3 Healthcare 8.98%
4 Financials 7.47%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
451
Zimmer Biomet
ZBH
$17.3B
$213K 0.02%
+1,845
New +$213K
SYKE
452
DELISTED
SYKES Enterprises Inc
SYKE
$213K 0.02%
7,735
-965
-11% -$26.1K
MC icon
453
Moelis & Co
MC
$4.88B
$212K 0.02%
+6,820
New +$214K
COR
454
DELISTED
Coresite Realty Corporation
COR
$212K 0.02%
+1,745
New +$210K
SPSC icon
455
SPS Commerce
SPSC
$2.17B
$209K 0.02%
+2,789
New +$170K
KIM icon
456
Kimco Realty
KIM
$17.4B
$208K 0.02%
+16,180
New +$180K
RJF icon
457
Raymond James Financial
RJF
$32.4B
$208K 0.02%
+4,538
New +$204K
AJG icon
458
Arthur J. Gallagher & Co
AJG
$62.2B
$207K 0.02%
+2,127
New +$188K
VWO icon
459
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$206K 0.02%
+5,208
New +$193K
SO icon
460
Southern Company
SO
$109B
$205K 0.02%
3,938
-631
-14% -$35.1K
VAC icon
461
Marriott Vacations Worldwide
VAC
$3.22B
$205K 0.02%
+2,490
New +$203K
WHD icon
462
Cactus
WHD
$3.85B
$205K 0.02%
+9,912
New +$172K
BMRN icon
463
BioMarin Pharmaceuticals
BMRN
$11.4B
$204K 0.02%
+1,658
New +$165K
KALU icon
464
Kaiser Aluminum
KALU
$2.95B
$204K 0.02%
+2,767
New +$197K
WST icon
465
West Pharmaceutical
WST
$25.1B
$204K 0.02%
+901
New +$177K
MEI icon
466
Methode Electronics
MEI
$569M
$203K 0.02%
+6,488
New +$195K
RMD icon
467
ResMed
RMD
$27.8B
$203K 0.02%
+1,057
New +$173K
BIO icon
468
Bio-Rad Laboratories Class A
BIO
$8.47B
$202K 0.02%
+447
New +$197K
CSW
469
CSW Industrials
CSW
$4.73B
$202K 0.02%
+2,918
New +$197K
FAF icon
470
First American
FAF
$7.03B
$202K 0.02%
+4,212
New +$199K
EG icon
471
Everest Group
EG
$14.9B
$201K 0.02%
971
-245
-20% -$47.7K
DVN icon
472
Devon Energy
DVN
$52.2B
$200K 0.02%
+17,694
New +$202K
WRI
473
DELISTED
Weingarten Realty Investors
WRI
$192K 0.02%
+10,145
New +$177K
RF icon
474
Regions Financial
RF
$26.2B
$184K 0.02%
16,600
-3,177
-16% -$33.8K
ABEV icon
475
Ambev
ABEV
$47.7B
$177K 0.02%
67,116
+32,326
+93% +$76.2K

Similar funds

Pitcairn's Q2 2020 Portfolio in Review

As of Q2 2020, Pitcairn held 540 positions worth $1.04B, up 23% from $845M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Pitcairn deployed $38.8M of net new capital in Q2 2020, opening 107 new positions and adding to 188 existing holdings. Its largest new stake was NYLI Hedge Multi-Strategy Tracker ETF: 352,967 shares worth $10.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR MSCI ACWI ex-US ETF, an estimated $4.67M trimmed.

  • Pitcairn's largest Q2 2020 buy was NYLI Hedge Multi-Strategy Tracker ETF: 352,967 shares worth $10.7M.
  • Pitcairn added most to State Street SPDR S&P International Small Cap ETF in Q2 2020, an estimated $10.4M increase.
  • Pitcairn's biggest Q2 2020 reduction was State Street SPDR MSCI ACWI ex-US ETF, cutting an estimated $4.67M.
  • Pitcairn fully exited Textron in Q2 2020, selling an estimated $924K.
  • Pitcairn's ten largest holdings make up 51% of its $1.04B portfolio in Q2 2020.
  • Pitcairn opened 107 new positions and closed 42 in Q2 2020.
  • Pitcairn's portfolio value rose 23% quarter-over-quarter to $1.04B.

Based on Pitcairn's 13F filing for Q2 2020, filed 28 Jul 2020.